SparkBio retweeted
Great story - Amira bought by BMS today. Less than $30M in equity raised, sold for $325M upfront. Nice to see another 10x+ deal in biotech
SparkBio retweeted
On @John_LaMattina's comments on Pfizer R&D cuts: Certainly agree, but it's not how much you got, it's how you use it >> http://j.mp/mQA7wu
SparkBio retweeted
So long as huge $ perceived as "winning," and not scientific advancement, #pharma R&D will continue to struggle.
SparkBio retweeted
Has bad management destroyed two generations of pharmaceutical research? My blog commenters are awfully smart: http://ow.ly/5wSQQ
SparkBio retweeted
Pharma is increasingly looking at academia to see how they can cut out the middleman of biotech." - Jit Patel, AstraZeneca #BIO2011
SparkBio retweeted
Forma鈥檚 deal with Genentech has echoes of LLC biz model, i.e. monetizing individual assets
SparkBio retweeted
Optimer readies antibiotic campaign after winning FDA panel vote. http://bit.ly/fqfyIp
SparkBio retweeted
Taking a closer look at the significance of statistical significance http://on.wsj.com/gDOkTF
SparkBio retweeted
>50% of academic findings can't be reproduced in biotech, driven in part by academic bias. Leads to biotech failures http://bit.ly/dUx06X
SparkBio retweeted
Q&A w/UCSF's Jeff Bluestone on the tricky balancing act between academia and industry. http://bit.ly/idQwCU










